These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11989305)

  • 21. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
    Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
    J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibroma with increased uptake of [F-18]-fluoro-2 deoxy-D-glucose interpreted as a metastatic lesion.
    Hsu CH; Lee CM; Wang FC; Fang CL
    Ann Nucl Med; 2003 Oct; 17(7):609-11. PubMed ID: 14651363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rapid diagnosis of recurrence of a tall cell variant of papillary thyroid cancer by endogenous TSH stimulation].
    Görges R; Liedke MO; Worm K; Frilling A; Bockisch A; Schmid KW
    Nuklearmedizin; 2003 Jun; 42(3):N15-8. PubMed ID: 12848153
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
    Laking GR; Price PM
    J Nucl Med; 2002 Dec; 43(12):1728-9; author reply 1729. PubMed ID: 12468527
    [No Abstract]   [Full Text] [Related]  

  • 25. Muscle uptake of 18-fluorine fluorodeoxyglucose.
    Bar-Shalom R
    Semin Nucl Med; 2000 Oct; 30(4):306-9. PubMed ID: 11105931
    [No Abstract]   [Full Text] [Related]  

  • 26. Arterial injection artifact on F-18 FDG positron emission tomographic scan.
    Bybel B; Kwok P; Neumann DR
    Clin Nucl Med; 2003 Apr; 28(4):350. PubMed ID: 12642728
    [No Abstract]   [Full Text] [Related]  

  • 27. F-18 fluorodeoxyglucose accumulation in an inflammatory pseudotumor of the spleen.
    Sato M; Takasaka I; Okumura T; Shioyama Y; Asato Y; Yoshimi F; Imura J; Amemiya R
    Ann Nucl Med; 2007 Nov; 21(9):521-4. PubMed ID: 18030584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary diagnosis of papillary thyroid carcinoma in the framework of staging of malignant melanoma with F-18 deoxyglucose using PET].
    Menzel C; Risse JH; Biersack HJ; Grünwald F
    Nuklearmedizin; 2001 Jun; 40(3):N23-4. PubMed ID: 11475082
    [No Abstract]   [Full Text] [Related]  

  • 30. PET image acquisition and analysis.
    Votaw JR
    Adv Neurol; 2000; 83():69-86. PubMed ID: 10999190
    [No Abstract]   [Full Text] [Related]  

  • 31. [Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy].
    Lorenzen J; de Wit M; Buchert R; Igel B; Bohuslavizki KH
    Nuklearmedizin; 1999; 38(8):333-6. PubMed ID: 10615668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intense FDG uptake in a benign Hurthle cell adenoma.
    Rohren EM
    Clin Nucl Med; 2004 Oct; 29(10):664-6. PubMed ID: 15365450
    [No Abstract]   [Full Text] [Related]  

  • 33. Focal F-18 fluorodexyglucose positron emission tomography uptake in a hyalinized nodule as a false positive splenic metastasis in a patient with breast cancer and metastatic thyroid cancer.
    Choi AY; Wax BN; Yung E
    Clin Nucl Med; 2005 Dec; 30(12):799-800. PubMed ID: 16319637
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
    Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
    Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.
    Kresnik E; Gallowitsch HJ; Mikosch P; Stettner H; Igerc I; Gomez I; Kumnig G; Lind P
    Surgery; 2003 Mar; 133(3):294-9. PubMed ID: 12660642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer.
    Feine U
    Eur J Endocrinol; 1998 May; 138(5):492-6. PubMed ID: 9625358
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
    Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomography.
    Nishiguchi S; Shiomi S; Ishizu H; Iwata Y; Kurooka H; Minamitani S; Habu D; Kawabe J; Ochi H
    Ann Nucl Med; 2001 Jun; 15(3):259-62. PubMed ID: 11545198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
    Low SC; Sinha AK; Sundram FX
    Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.